Niki BioSolutions, Inc. Other Operating Income (Expense), Net
Niki BioSolutions, Inc. (NIKI) reported Other Operating Income (Expense), Net of $170.76 thousand for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2026-05-11
- Niki BioSolutions, Inc. other operating income (expense), net for the quarter ending 2025-12-31 was -$116.22K.
- Niki BioSolutions, Inc. other operating income (expense), net for the quarter ending 2025-09-30 was $64.07K, a 8.67% decline year-over-year.
- Niki BioSolutions, Inc. other operating income (expense), net for the quarter ending 2024-12-31 was -$205.52K.
- Niki BioSolutions, Inc. other operating income (expense), net for the quarter ending 2024-09-30 was $70.15K.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month | Other Operating Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$116.22K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | -$52.16K derived: sum of 2 quarters · filed 2026-05-11 | $170.76K S-4/A · filed 2026-05-11 | |
| 2025-09-30 | $64.07K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | $286.98K 6-K · filed 2026-01-22 | ||
| 2025-06-30 | $222.91K 6-K · filed 2025-10-08 | |||
| 2024-12-31 | -$205.52K derived: S-4/A 12 month − 6-K 9 month · filed 2026-05-11 | -$135.38K derived: sum of 2 quarters · filed 2026-05-11 | -$272.61K S-4/A · filed 2026-05-11 | |
| 2024-09-30 | $70.15K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | -$67.09K 6-K · filed 2026-01-22 | ||
| 2024-06-30 | -$137.23K 6-K · filed 2025-10-08 | |||
| 2023-12-31 | -$1.07M S-4/A · filed 2026-05-11 | |||
| 2022-12-31 | -$261.04K 6-K · filed 2025-10-08 |